Fitch also affirmed an “AA-” rating for nearly $489 million in parity debt issued on behalf of GHS. Key rating drivers include solid interim performance. For the nine months ended June 30, the GHS obligated group posted a 4.3 percent operating margin and 9.6 percent operating EBITDA margin. Volume also increased, with inpatient admissions up 4 percent, inpatient surgeries up 3 percent and outpatient surgeries up 15 percent.
Additionally, GHS’ strategic investments in academics and reform initiatives (such as a new clinical IT system) and positive underlying credit factors (the health system’s 63.9 percent inpatient market share, for instance) drove the credit rating, according to Fitch.
More articles on hospital finance:
For-profit health systems see dramatic Medicaid shifts in expansion states
McKenzie County Healthcare Systems to build new medical campus
CMS makes offer to help clear Medicare claims backlog
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
